Simplifying Global Compliance
Tufts: Biologics Makers Need More Adaptable Strategies
Makers of biopharmaceuticals will need to become more modular and agile to adjust for trends in personalized medicine and oncology, according to the Tufts Center for the Study of Drug Development.
To View This Article:
Subscribe To Generic Line
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing